New York State Common Retirement Fund’s Arcus Biosciences RCUS Stock Holding History

New York State Common Retirement Fund’s Portfolio RCUS Stock Details RCUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$970K	Buy	31,454 +5,400	+21%	+$133K	﹤0.01%	1768
2026 Q1	$563K	Sell	26,054 -16,948	-39%	-$366K	﹤0.01%	1864
2025 Q4	$1.02M	Buy	43,002 +21,148	+97%	+$431K	﹤0.01%	1695
2025 Q3	$297K	Buy	21,854 +8,300	+61%	+$86.3K	﹤0.01%	2126
2025 Q2	$110K	Hold	13,554	–	–	﹤0.01%	2522
2025 Q1	$106K	Hold	13,554	–	–	﹤0.01%	2482
2024 Q4	$202K	Hold	13,554	–	–	﹤0.01%	2290
2024 Q3	$207K	Sell	13,554 -7,200	-35%	-$114K	﹤0.01%	2281
2024 Q2	$316K	Buy	20,754 +454	+2%	+$7.33K	﹤0.01%	2227
2024 Q1	$383K	Hold	20,300	–	–	﹤0.01%	2179
2023 Q4	$388K	Sell	20,300 -556	-3%	-$8.89K	﹤0.01%	2198
2023 Q3	$374K	Sell	20,856 -15,256	-42%	-$307K	﹤0.01%	2168
2023 Q2	$733K	Sell	36,112 -13,347	-27%	-$254K	﹤0.01%	1915
2023 Q1	$902K	Sell	49,459 -2,818	-5%	-$53.9K	﹤0.01%	1903
2022 Q4	$1.08M	Buy	52,277 +3,348	+7%	+$92.1K	﹤0.01%	1931
2022 Q3	$1.28M	Buy	48,929 +2,853	+6%	+$75.5K	﹤0.01%	1853
2022 Q2	$1.17M	Buy	46,076 +4,031	+10%	+$98.7K	﹤0.01%	1928
2022 Q1	$1.33M	Buy	42,045 +9,375	+29%	+$314K	﹤0.01%	1953
2021 Q4	$1.32M	Sell	32,670 -85	-0.3%	-$3.3K	﹤0.01%	1994
2021 Q3	$1.14M	Sell	32,755 -5,804	-15%	-$181K	﹤0.01%	2061
2021 Q2	$1.06M	Buy	38,559 +359	+0.9%	+$10.3K	﹤0.01%	2206
2021 Q1	$1.07M	Hold	38,200	–	–	﹤0.01%	2096
2020 Q4	$992K	Buy	38,200 +8,900	+30%	+$215K	﹤0.01%	2051
2020 Q3	$502K	Hold	29,300	–	–	﹤0.01%	2214
2020 Q2	$725K	Hold	29,300	–	–	﹤0.01%	2038
2020 Q1	$407K	Hold	29,300	–	–	﹤0.01%	2145
2019 Q4	$296K	Sell	29,300 -1,900	-6%	-$16K	﹤0.01%	2550
2019 Q3	$284K	Hold	31,200	–	–	﹤0.01%	2594
2019 Q2	$248K	Hold	31,200	–	–	﹤0.01%	2713
2019 Q1	$390K	Buy	31,200 +24,900	+395%	+$270K	﹤0.01%	2420
2018 Q4	$68K	Hold	6,300	–	–	﹤0.01%	3054
2018 Q3	$88K	Hold	6,300	–	–	﹤0.01%	3062
2018 Q2	$77K	Buy	+6,300	New	+$98.9K	﹤0.01%	3119

Other funds holding RCUS

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

New York State Common Retirement Fund's RCUS Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Arcus Biosciences (RCUS) stake by 21% in Q2 2026, buying an estimated $133K and bringing the position to 31,454 shares worth $970K. The position accounts for ﹤0.01% of the portfolio, ranked #1768.

New York State Common Retirement Fund first reported a position in RCUS in Q2 2018 and has held it in 33 quarters since. The position peaked at $1.33M in Q1 2022. 231 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

New York State Common Retirement Fund held 31,454 shares of Arcus Biosciences worth $970K as of Q2 2026.
New York State Common Retirement Fund bought 5,400 Arcus Biosciences shares in Q2 2026, an estimated $133K.
Arcus Biosciences made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1768 holding.
New York State Common Retirement Fund first reported a position in Arcus Biosciences in Q2 2018 and has held it in 33 quarters since.
New York State Common Retirement Fund's Arcus Biosciences position peaked at $1.33M in Q1 2022.
231 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.